We next investigated the expression of integrins, ligands, and receptors that were differentially expressed on the tumor 48 h after the second treatment with either PBS/IgG isotype or IL-15 complexes, or after anti-PD-1 therapy. This evidence concerns the gene IL15 and neoplasm.